JORGE SOLER IGLESIAS: Open Payments
NPI 1104313402 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 43 payments from 16 companies in 2025. Trend: 2023 $1,365 · 2024 $1,094 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $317 |
| AstraZeneca Pharmaceuticals LP | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Viatris Specialty LLC | 3 | $69 |
| Dexcom, Inc. | 3 | $60 |
| ABBVIE INC. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Lilly USA, LLC | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
Products named: Ozempic, Wegovy, REXULTI, TRELEGY ELLIPTA, YUPELRI, AIRSUPRA, Dexcom G6 Transmitter, Kerendia.
Industry payments across CA — which companies pay providers there.
